InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Chung Jane. Officer active across 1 company, notably Sutro Biopharma, INC.. Aggregated, 14 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €9k. History available since 9 August 2022. The latest transaction was filed on 4 March 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations
Jane Chung is a declarant linked to Sutro Biopharma, INC. on XNAS, where the listed role is PRESIDENT AND COO. The record shows 9 filings in total, and the 9 sampled filings cover the period from 2022-08-10 to 2025-03-06, with the modal transaction nature listed as option exercise.